• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制定阿尔茨海默病及其他痴呆症的治疗指南。

Developing Treatment Guidelines for Alzheimer's Disease and Other Dementias.

作者信息

Rabins P V

机构信息

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA.

出版信息

J Clin Psychiatry. 1998;59 Suppl 11:17-9.

PMID:9731546
Abstract

Escalating health care costs and evidence that there is widespread variation in medical practice have led to the formation of more than 1800 consensus conferences in the past 10 years. These conferences seek to review the evidence that existing treatments have demonstrable efficacy; to determine if evidence favors one form of therapy over another; to review the guidelines for implementation, continuation, and discontinuation of the therapy; and to identify currently used treatments for which no benefit can be documented. This is a review of the process used by the American Psychiatric Association Task Force on Developing Treatment Guidelines for Alzheimer's Disease and Other Dementias, still in process at the time of this presentation.

摘要

不断攀升的医疗保健成本以及医学实践中存在广泛差异的证据,导致在过去十年中召开了1800多次共识会议。这些会议旨在审查现有治疗方法具有明显疗效的证据;确定证据是否支持一种治疗形式优于另一种;审查治疗实施、持续和停止的指南;并确定目前使用的但无法证明有疗效的治疗方法。这是对美国精神病学协会阿尔茨海默病和其他痴呆症治疗指南制定特别工作组所采用过程的综述,在本报告撰写之时该工作仍在进行中。

相似文献

1
Developing Treatment Guidelines for Alzheimer's Disease and Other Dementias.制定阿尔茨海默病及其他痴呆症的治疗指南。
J Clin Psychiatry. 1998;59 Suppl 11:17-9.
2
Developing treatment guidelines for Alzheimer's disease and other dementias.制定阿尔茨海默病及其他痴呆症的治疗指南。
J Clin Psychiatry. 1996;57 Suppl 14:37-8.
3
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.世界生物精神病学学会联合会(WFSBP)关于阿尔茨海默病和其他痴呆症的生物治疗指南。
World J Biol Psychiatry. 2011 Feb;12(1):2-32. doi: 10.3109/15622975.2010.538083.
4
Recommendations for best practices in the treatment of Alzheimer's disease in managed care.管理式医疗中阿尔茨海默病治疗的最佳实践建议。
Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28. doi: 10.1016/j.amjopharm.2006.10.001.
5
Alzheimer's disease. AMA Council on Scientific Affairs Reference Committee D.阿尔茨海默病。美国医学协会科学事务委员会参考委员会D。
J Okla State Med Assoc. 1998 Aug;91(5):298-306.
6
Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.多奈哌齐在常规临床实践中对参加大型医疗保险管理式医疗计划的阿尔茨海默病及相关痴呆症患者医疗费用的影响:一项病例对照研究。
Am J Geriatr Pharmacother. 2005 Jun;3(2):92-102. doi: 10.1016/j.amjopharm.2005.07.001.
7
Late-life dementia. Review of the APA guidelines for patient management.老年痴呆症。美国心理学会患者管理指南综述。
Geriatrics. 2000 Oct;55(10):55-60; quiz 62.
8
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition.美国精神病学协会《阿尔茨海默病及其他痴呆症患者治疗实践指南》。第二版。
Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56.
9
Dementia predicted to double in next 20 years--advice on Alzheimer's and other dementias.预计未来20年痴呆症患者数量将翻倍——关于阿尔茨海默病及其他痴呆症的建议
N Z Health Hospital. 1997 May-Jun;49(3):9.
10
Managed care decisions in Alzheimer's disease.阿尔茨海默病的管理式医疗决策
Am J Manag Care. 2000 Dec;6(22 Suppl):S1149-55; discussion S1156-60.

引用本文的文献

1
Heparin oligosaccharides as potential therapeutic agents in senile dementia.肝素寡糖作为老年痴呆症的潜在治疗药物。
Curr Pharm Des. 2007;13(15):1607-16. doi: 10.2174/138161207780765918.
2
Prevention of Alzheimer's disease: where we stand.阿尔茨海默病的预防:我们目前的进展
Curr Neurol Neurosci Rep. 2002 Sep;2(5):392-9. doi: 10.1007/s11910-002-0064-8.